Multaq: When to Call the Doctor
As with most medications on the market today, Multaq comes with a set of warnings. The fact that the drug can cause severe conditions like liver failure and abnormal heart...
European Medicines Agency Reviews Multaq
The European Medicines Agency’s Committee on Medicinal Products for Human Use met Sept. 2 to talk about the ongoing review of Multaq’s benefits and risks. At the request of the...
Sanofi-Aventis Formally Alerts Doctors of Halted Multaq Study
In keeping with all of the news surrounding a halted Multaq study, Sanofi-Aventis, the makers of the drug, has formally alerted doctors that one of the Multaq clinical studies for...
EMA Recommends that Doctors Conduct Liver Function Tests Before Using Multaq Treatments
Back in February, the European Medicines Agency (EMA) recommended that doctors who are considering prescribing Multaq to patients suffering from temporary atrial fibrillation should perform liver function tests before doing...
Multaq Dangers Forced Sanofi-Aventis to Send Another “Dear Doctor” Warning Letter
Back in January of this year, it was announced that drug maker Sanofi-Aventis was going to send out a “Dear Doctor” letter as a warning to physicians that the company’s...